The STRN-ALK fusion gene, a new driver gene, has been found in multiple cancers, including thyroid cancer [10], non-small-cell lung cancer (NSCLC) [11], colorectal cancer [12], and renal carcinoma [13]. This evidence concerns the gene ALK and non-small cell lung carcinoma.